Ras-mediated Up-regulation of Survivin Expression in Cytokine-dependent Murine Pro-B Lymphocytic Cells

この論文にアクセスする

この論文をさがす

著者

    • SHINJYO TETSUHARU
    • Department of Endocrinology and Metabolism, Department of Internal Medicine, University of the Ryukyus, School of Medicine
    • MIYAGI JUN-ICHI
    • Department of Endocrinology and Metabolism, Department of Internal Medicine, University of the Ryukyus, School of Medicine
    • OHAMA KIYOTO
    • Department of Endocrinology and Metabolism, Department of Internal Medicine, University of the Ryukyus, School of Medicine
    • MASUDA MASATO
    • Department of Endocrinology and Metabolism, Department of Internal Medicine, University of the Ryukyus, School of Medicine
    • NAGASAKI AKITOSHI
    • Department of Endocrinology and Metabolism, Department of Internal Medicine, University of the Ryukyus, School of Medicine
    • MATSUI HIROTAKA
    • Department of Developmental Biology and Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University
    • INABA TOSHIYA
    • Department of Developmental Biology and Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University
    • FURUKAWA YUSUKE
    • Division of Stem Cell Regulation Center for Molecular Medicine, Jichi Medical School
    • TAKASU NOBUYUKI
    • Department of Endocrinology and Metabolism, Department of Internal Medicine, University of the Ryukyus, School of Medicine

抄録

Survivin, a member of the inhibitor of apoptosis protein (IAP) family, has been widely studied because of its aberrant expression in human cancer. Survivin has multiple functions, including cell-cycle regulation at mitosis, inhibition of apoptosis and caspase-independent cytoprotection. Clinical studies have shown that survivin is associated with resistance to treatment and its expression is linked to poor prognosis. Recent studies indicated that Ras pathways up-regulate survivin expression in hematopoietic cells. Here we analyzed downstream pathways of Ras in interleukin-3 (IL-3)-dependent Baf-3 murine-derived pro-B lymphocytic cells that express constitutively active Ras mutants, using signaling pathway-specific inhibitors. Both mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3-K) pathways are involved in the induction of survivin. Downstream of PI3-K, the signaling pathway is composed of two kinases, Akt and mammalian target of rapamycin (mTOR) pathways. In the downstream targets of PI3-K, mTOR but not Akt is responsible for survivin expression. Using a counterflow centrifugal elutriator, we observed G2/M phase-dominant survivin expression in Baf-3 cells. Interestingly, constitutively active Ras mutants also induced survivin in a cell cycle-dependent manner. Reporter assays of the survivin gene promoter revealed a transcriptional regulatory cis-acting region that is responsible for Ras signaling, indicating that Ras increases the transcription of the survivin gene through specific enhancer elements. These data illustrate the pathways regulating survivin expression by Ras. Ras activates the MAPK, PI3-K and mTOR pathways, and these signals enhance survivin transcription. Our data will provide the new information about mechanisms of survivin expression by Ras-signalling pathways.

収録刊行物

  • THE TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE  

    THE TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE 216(1), 25-34, 2008-09-01 

    Tohoku University Medical Press

参考文献:  15件

参考文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

キーワード

各種コード

  • NII論文ID(NAID)
    10021951575
  • NII書誌ID(NCID)
    AA00863920
  • 本文言語コード
    ENG
  • 資料種別
    ART
  • ISSN
    00408727
  • データ提供元
    CJP書誌  J-STAGE 
ページトップへ